Advertisement

Topics

Edge BioSystems Company Profile

03:54 EDT 24th October 2017 | BioPortfolio

Edge BioSystems is a stable and established research reagents company located in Gaithersburg, MD. Edge has been in business for more than 14 years. We are looking for aggressive and dynamic individuals who have an interest in bringing new reagents and tools to the research community

Location

19208 Orbit Drive
Gaithersburg
Maryland
20879
United States of America

Contact

Fax: 1-301-990-0881
Email: hr@edgebio.com


News Articles [205 Associated News Articles listed on BioPortfolio]

T2 Biosystems nets $16.5mm via FOPO

Diagnostics firm T2 Biosystems Inc. netted $16.45mm through the follow-on sale of 4.38mm common shares at $4.

Leica Biosystems Celebrates 2,000 Global Digital Pathology Scanner Installations

VISTA, Calif., Sept. 21, 2017 /PRNewswire/ -- Leica Biosystems announced that it has delivered and installed its 2,000th digital pathology scanner. This is a key milestone for both the company an...

Genera Biosystems: Diagnostics Come of Age

In early 2008 Genera Biosystems was floated on the ASX and, despite the current economic environment, the CEO, Allen Bollands is feeling positive about the company’s future. He predicts that a ‘go...

CDC, T2 Biosystems team up on Candida auris testing, monitoring

T2 Biosystems and the CDC entered into a collaboration enabling the CDC to use T2's T2Dx instrument for the testing and monit -More- 

EU OKs bacterial panel from T2 Biosystems

T2 Biosystems' T2Bacteria Panel has been granted CE mark approval by European regulators.  -More- 

TARA Biosystems Taps MyoKardia’s Michael Graziano for CSO Post

Michael Graziano is joining TARA Biosystems to become the New York company’s chief scientific officer. TARA Biosystems is developing “heart-on-a-chip” tissue models that can be used in drug dis...

Imagion Biosystems closes $A12mm IPO on ASX

Imagion Biosystems Ltd. (cancer detection) grossed $A12mm ($9mm) through its initial public offering on the Australian Securities Exchange of 60mm new shares at $A0.20.

Applied BioSystems 9800 Fast Thermal Cycler

$1,999.99End Date: Sunday Aug-6-2017 20:32:53 PDTBuy It Now for only: $1,999.99Buy It Now | Add to watch list Biotech365 : Applied BioSystems 9800 Fast Thermal Cycler BioMarketplace You want to p...

PubMed Articles [290 Associated PubMed Articles listed on BioPortfolio]

Relapse of Mitral Regurgitation Due to Tethering after Valve Plasty with Edge-to-edge Repair;Report of a Case.

A 75-year-old woman with severe mitral regurgitation (MR) successfully underwent mitral valve plasty with edge-to-edge plasty and commissural annuloplasty. Three days after the operation, she was foun...

End-Tidal CO2 Predicts Reduction in Mitral Regurgitation in Patients Undergoing Percutaneous Mitral Valve Edge-to-Edge Repair.

We evaluated end-tidal CO2 (etCO2), which has been proposed to assess acute hemodynamic changes, to guide percutaneous edge-to-edge mitral valve repair (PMVR) with the MitraClip system.

Reaching Non-Negative Edge Consensus of Networked Dynamical Systems.

In this paper, the problem of non-negative edge consensus of undirected networked linear time-invariant systems is addressed by associating each edge of the network with a state variable, for which a ...

Analytical study of the edge states in the bosonic Haldane model.

We investigate the properties of magnon edge states in a ferromagnetic honeycomb spin lattice with a Dzialozinskii-Moriya interaction (DMI). We derive analytical expressions for the energy spectra and...

Fracture toughness enhancement of h-BN monolayers via hydrogen passivation of a crack edge.

Molecular dynamics-based simulations were performed in conjunction with reactive force-field potential parameters to investigate the effect of crack-edge passivation via hydrogenation on the fracture ...

Clinical Trials [65 Associated Clinical Trials listed on BioPortfolio]

REPRISE EDGE 29 mm EU Study

The objective of the REPRISE EDGE 29 mm EU study is to evaluate performance and safety of the 29 mm LOTUS Edge™ Valve System for transcatheter aortic valve replacement (TAVR) in symptoma...

REpositionable Percutaneous Replacement of NatIve StEnotic Aortic Valve Through Implantation of LOTUS EDGE Valve System

The objective of the REPRISE EDGE study is to confirm the acute performance and safety of the LOTUS Edge™ Valve System when used with the Lotus™ or iSleeve™ Introducer Set for transc...

MitraClip® After Surgical Mitral Valve Repair

Percutaneous edge-to-edge repair of the mitral valve has been shown to be a safe and effective alternative treatment option for selected patients at high risk for cardiac surgery. Patients...

How Well Does the Data Obtained From Heidelberg Edge Perimeter Visual Field Compare to Standard Octopus Visual Field

The purpose of this study is to compare standard automated perimetry (SAP) using the Heidelberg Edge Perimeter (HEP) with the Octopus Visual Field (OVF) analyzer and determine test-retest ...

Subjective and Conjunctival Response to Edge Design of Different Silicone Hydrogels

The purpose of this study is to evaluate the effect of different contact lens edge designs on the conjunctiva.

Companies [745 Associated Companies listed on BioPortfolio]

Edge BioSystems

Edge BioSystems is a stable and established research reagents company located in Gaithersburg, MD. Edge has been in business for more than 14 years. We are looking for aggressive and dynamic indiv...

Novacta Biosystems Limited

Novacta Biosystems is a biotechnology company with a proprietary technology platform that harnesses the specificity and efficiency of biological systems, including biosynthetic pathway engineering, bi...

Vision BioSystems Inc

Vision BioSystems designs, manufactures and distributes quality products for use in diagnosis of cancer and infectious diseases. We are committed to furthering scientific understanding and diagnostic ...

X2 Biosystems

X2 Biosystems is a privately held Seattle-based science and technology company that has developed the world’s first systems for comprehensive, end-to-end, real-time managemen...

Silicon Biosystems, Inc.

Silicon Biosystems, Inc. was formed in October of 2010 as a wholly owned subsidiary of Silicon Biosystems, S.p.A. based in Bologna, Italy. The Company manufactures and sells the D...

More Information about "Edge BioSystems" on BioPortfolio

We have published hundreds of Edge BioSystems news stories on BioPortfolio along with dozens of Edge BioSystems Clinical Trials and PubMed Articles about Edge BioSystems for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Edge BioSystems Companies in our database. You can also find out about relevant Edge BioSystems Drugs and Medications on this site too.

Quick Search
Advertisement
 

Corporate Database Quicklinks



Searches Linking to this Company Record